Agence nationale de sécurité du médicament et des produits de santé
The Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM) was formed in on 1 May 2012 following a number of drug and device regulatory scandals in France. It incorporated the Agence Française de Sécurité Sanitaire des Produits de Santé (often abbreviated as AFSSAPS or AFSSaPS) which was the French medical drugs and device regulation agency. It was given new powers which included relevant research and patient monitoring with mandatory data collection. An early goal was announced to be to reassess the benefit / risk of certain drugs. This is likely to mean in particular ones that have been licensed in France but not elsewhere, but recently France has also acted out of step with other European Regulatory agencies upon drugs licensed under the common EU procedures, based on evidence from French studies alone, so reviews may not be confined to such products. It has new roles in educating patients on the use of health products and strengthened conflict of interest policy.